These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12902984)

  • 21. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
    Jiang J; Slivova V; Sliva D
    Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA methylation inhibitor, procainamide, may decrease the tamoxifen resistance by inducing overexpression of the estrogen receptor beta in breast cancer patients.
    Altundag O; Altundag K; Gunduz M
    Med Hypotheses; 2004; 63(4):684-7. PubMed ID: 15325017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenylation inhibitors stimulate both estrogen receptor alpha transcriptional activity through AF-1 and AF-2 and estrogen receptor beta transcriptional activity.
    Cestac P; Sarrabayrouse G; Médale-Giamarchi C; Rochaix P; Balaguer P; Favre G; Faye JC; Doisneau-Sixou S
    Breast Cancer Res; 2005; 7(1):R60-70. PubMed ID: 15642170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells.
    Lee SO; Nadiminty N; Wu XX; Lou W; Dong Y; Ip C; Onate SA; Gao AC
    Cancer Res; 2005 Apr; 65(8):3487-92. PubMed ID: 15833885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.
    Lindberg K; Ström A; Lock JG; Gustafsson JA; Haldosén LA; Helguero LA
    J Cell Physiol; 2010 Jan; 222(1):156-67. PubMed ID: 19780039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A HOXA10 estrogen response element (ERE) is differentially regulated by 17 beta-estradiol and diethylstilbestrol (DES).
    Akbas GE; Song J; Taylor HS
    J Mol Biol; 2004 Jul; 340(5):1013-23. PubMed ID: 15236964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
    Girgert R; Hanf V; Emons G; Gründker C
    J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tamoxifen induces the expression of maspin through estrogen receptor-alpha.
    Liu Z; Shi HY; Nawaz Z; Zhang M
    Cancer Lett; 2004 Jun; 209(1):55-65. PubMed ID: 15145521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation.
    King ML; Adler SR; Murphy LL
    Integr Cancer Ther; 2006 Sep; 5(3):236-43. PubMed ID: 16880429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue.
    Leygue E; Dotzlaw H; Watson PH; Murphy LC
    Cancer Res; 1999 Mar; 59(6):1175-9. PubMed ID: 10096542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
    Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
    Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone deacetylase inhibition and estrogen signalling in human breast cancer cells.
    Margueron R; Duong V; Castet A; Cavaillès V
    Biochem Pharmacol; 2004 Sep; 68(6):1239-46. PubMed ID: 15313422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of mRNA for oestrogen receptor beta splice variants ERbeta1, ERbeta2/ERbetacx and ERbeta5 with outcome in endocrine-treated breast cancer.
    Davies MP; O'Neill PA; Innes H; Sibson DR; Prime W; Holcombe C; Foster CS
    J Mol Endocrinol; 2004 Dec; 33(3):773-82. PubMed ID: 15591034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
    Sauvé K; Lepage J; Sanchez M; Heveker N; Tremblay A
    Cancer Res; 2009 Jul; 69(14):5793-800. PubMed ID: 19584281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of estrogen receptor beta in breast cancer.
    Saji S; Hirose M; Toi M
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():21-6. PubMed ID: 16273360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human.
    Ogawa S; Inoue S; Watanabe T; Orimo A; Hosoi T; Ouchi Y; Muramatsu M
    Nucleic Acids Res; 1998 Aug; 26(15):3505-12. PubMed ID: 9671811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of estrogen receptor isoforms in the pathogenesis and treatment of endometrial cancer].
    Hanstein B; Beckmann MW; Bender HG
    Zentralbl Gynakol; 2002 Jan; 124(1):17-9. PubMed ID: 11873309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ERbeta1 and the ERbeta2 splice variant (ERbetacx/beta2) are expressed in distinct cell populations in the adult human testis.
    Saunders PT; Millar MR; Macpherson S; Irvine DS; Groome NP; Evans LR; Sharpe RM; Scobie GA
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2706-15. PubMed ID: 12050238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen receptors β1 and β2 are associated with distinct responses of estrogen receptor α-positive breast carcinoma to adjuvant endocrine therapy.
    Dhimolea E; Tiniakos DG; Chantzi ΝΙ; Goutas N; Vassilaros SD; Mitsiou DJ; Alexis ΜN
    Cancer Lett; 2015 Mar; 358(1):37-42. PubMed ID: 25524554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.